Phase II study of maytansine in advanced sarcomas
Edmonson, J.H.; Hahn, R.G.; Creagan, E.T.; O'Connell, M.J.
Cancer Treatment Reports 67(4): 401-402
1983
ISSN/ISBN: 0361-5960 PMID: 6850657 Document Number: 211060
Document emailed within 1 workday
Related Documents
Edmonson, J.H.; Rubin, J.; Kvols, L.K.; O'Connell, M.J.; Frytak, S.; Green, S.J. 1981: Phase II study of maytansine in advanced breast cancer Cancer Treatment Reports 65(5-6): 536-537Rosenthal, S.; Harris, D.T.; Horton, J.; Glick, J.H. 1980: Phase II study of maytansine in patients with advanced lymphomas: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 64(10-11): 1115-1117
Chahinian, A.P.; Nogeire, C.; Ohnuma, T.; Greenberg, M.L.; Sivak, M.; Jaffrey, I.S.; Holland, J.F. 1979: Phase I study of weekly maytansine given by iv bolus or 24-hour infusion Cancer Treatment Reports 63(11-12): 1953-1960
Di Lauro, L.; Balice, A.; Papaldo, P.; Lopez, M. 1985: Mitomycin C in the treatment of sarcomas of the soft tissues in the adult in an advanced phase La Clinica Terapeutica 115(2): 83-85
Ratanatharathorn, V.; Gad-el-Mawla, N.; Wilson, H.E.; Bonnet, J.D.; Rivkin, S.E.; Mass, R. 1982: Phase II evaluation of maytansine in refractory non-Hodgkin's lymphoma: a Southwest Oncology Group study Cancer Treatment Reports 66(7): 1687-1688
Eagan, R.T.; Creagan, E.T.; Ingle, J.N.; Frytak, S.; Rubin, J. 1978: Phase II evaluation of maytansine in patients with metastatic lung cancer Cancer Treatment Reports 62(10): 1577-1579
Saiki, J.H.; Baker, L.H.; Stephens, R.L.; Fabian, C.J.; Kraut, E.H.; Fletcher, W.S. 1982: Gallium nitrate in advanced soft tissue and bone sarcomas: a Southwest Oncology Group Study Cancer Treatment Reports 66(8): 1673-1674
Buesa, J.M.; Mouridsen, H.T.; Santoro, A.; Somers, R.; Bramwell, V.; van Oosterom, A.T.; Wagener, T.; Vendrik, C.; Thomas, D. 1984: Treatment of advanced soft tissue sarcomas with low-dose methotrexate: a phase Ii trial by the European Organization of Research on Treatment for Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Cancer Treatment Reports 68(4): 683-684
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Yoshida, T.; Nakanishi, J.; Ito, K.; Kobayashi, S.; Ohtake, S.; Nakamura, S.; Hattori, K. 1984: Phase Ii study of etoposide (NK 171) in advanced hematological malignancies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1579-1584
Tropé, C.; Mattsson, W.; Gynning, I.; Johnsson, J.E.; Sigurdsson, K.; Orbert, B. 1981: Phase Ii study of spirogermanium in advanced ovarian malignancy Cancer Treatment Reports 65(1-2): 119-120
Rouësse, J.G.; Le Chevalier, T.; Caille, P.; Mondesir, J.M.; Sancho-Garnier, H.; May-Levin, F.; Spielmann, M.; De Jager, R.; Amiel, J.L. 1985: Phase Ii study of elliptinium in advanced breast cancer Cancer Treatment Reports 69(6): 707-708
Ettinger, D.S.; Orr, D.W.; Rice, A.P.; Donehower, R.C. 1985: Phase i study of N-methylformamide in patients with advanced cancer Cancer Treatment Reports 69(5): 489-493
Lionetto, R.; Pronzato, P.; Conte, P.F.; Sertoli, M.R.; Amoroso, D.; Rosso, R. 1986: Idarubicin in advanced breast cancer: a phase II study Cancer Treatment Reports 70(12): 1439-1440
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Yap, H.Y.; Salem, P.; Hortobagyi, G.N.; Bodey, G.P.; Buzdar, A.U.; Tashima, C.K.; Blumenschein, G.R. 1978: Phase Ii study of cis-dichlorodiammineplatinum(II) in advanced breast cancer Cancer Treatment Reports 62(3): 405-408
Hakes, T.B.; Raymond, V. 1987: Phase Ii study of idarubicin in advanced endometrial carcinoma Cancer Treatment Reports 71(5): 535-536
Lawton, J.O.; Giles, G.R.; Hall, J.; MacAdam, A.; Hall, R.; Matheson, T.; Bird, G. 1981: Phase Ii study of chlorozotocin in the treatment of advanced colorectal cancer Cancer Treatment Reports 65(1-2): 13-15
Wiltshaw, E.; Kroner, T. 1976: Phase Ii study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary Cancer Treatment Reports 60(1): 55-60
Kurtz, J.E.; Kohser, F.; Négrier, S.; Trillet-Lenoir, V.; Walter, S.; Limacher, J.M.; Untereiner, M.; Kayitalire, L.; Jaeck, D.; Dufour, P. 2000: Gemcitabine and protracted 5-FU for advanced pancreatic cancer. A phase II study Hepato-Gastroenterology 47(35): 1450-1453